Companhia Brasileira de Distribuicao (NYSE:CBD) does about 965.69K shares in volume on a normal day but saw 2446814 shares change hands in Friday trading. The company now has a market cap of 975.82M USD. Its current market price is $3.67, marking an increase of 1.10% compared to the previous close of $3.63. The 52 week high reached by this stock is $5.50 whilst the lowest price level in 52 weeks is $2.73. The script in recent trading has seen the stock touch a high of $3.76 and a low of $3.56.
Companhia Brasileira de Distribuicao (CBD) has a 20-day trading average at $3.36 and the current price is -33.24% off the 52-week high compared with 34.43% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.45 and its 200-day simple moving average is $3.76. If we look at the stock’s price movements over the week, volatility stands at 4.27%, which decreases to 4.21% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 58.19 to suggest the stock is neutral.
10 analysts observing the Companhia Brasileira de Distribuicao (CBD) stock have set the 12-month price targets for the company’s shares at between $4.00 and $7.47. The consensus objective for the share price is $5.50, suggesting that the stock has a potential upside of 33.27% over the period. The median price target is 13.85% away from the current levels at $4.26.
FactSet Research has provided data showing that 10 brokerages have issued ratings for the stock. 1 analysts have rated it as a sell, while 0 advise that it is a overweight. 4 analysts have rated it as a buy and 5 have advised that investors hold their positions. The consensus recommendation rating is Overweight and Wall Street’s advice is for investors to Moderate Buy the stock.
The current price level is 9.52%, 6.26%, and -2.46% away from its SMA20, SMA50, and SMA200 respectively, with the CBD price moving below the 50-day SMA on January 20. Companhia Brasileira de Distribuicao (CBD) stock is up 0.55% over the week and 15.77% over the past month. Its price is 18.39% year-to-date and 1.31% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2022, with the company’s earnings per share (EPS) of -$0.13 below consensus estimates by -$0.11. The company’s next earnings report is expected on 05/03/2023, with forecasts estimating quarterly EPS at -$0.18 and -$0.02 for whole year. CBD’s earnings per share are forecast to shrink by -103.60% this year and 1,750.00% over next year.
Its 12-month price target is $4.26. To reach the target analysts have set, the stock logically needs to grow 33.27 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $4.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $7.47.
Outstanding shares total 269.00M with insiders holding 0.00% of the shares and institutional holders owning 5.95% of the company’s common stock. The company has a return on investment of 7.90% and return on equity of 12.20%. The price to earnings ratio (P/E ratio) amounts to 15.96 while the forward price to earnings ratio is 11.12. The beta has a value of 1.19. Price to book ratio is 0.38 and price to sales ratio is 0.11.
Avantis Emerging Markets Equity E raise their holdings by 0.59% in the company over the course of the most recent quarter. It now holds a 0.13% position in Companhia Brasileira de Distribuicao thanks to 0.34 million shares amounting to $1.06 million.